Compound

Letrozole

ATC Index

Letrozole: Uses, Dosage, Side Effects, & How to Buy Safely

Discover comprehensive information about <strong>Letrozole</strong>, an aromatase inhibitor primarily used for breast cancer treatment. Learn about its benefits, proper dosage, potential side effects, and safe acquisition.

Letrozole buy Letrozole Letrozole for sale Letrozole dosage Letrozole side effects aromatase inhibitor breast cancer treatment fertility medication
ATC Code: E07
Last updated: Feb 23, 2026
Medical Reference

Looking to order Letrozole?

Browse our catalog for available pharmaceutical products and competitive pricing.

View Products

What is Letrozole?

Letrozole is a potent, selective, non-steroidal aromatase inhibitor widely utilized in oncology, particularly for hormone-receptor-positive breast cancer. It functions by blocking the enzyme aromatase, which is responsible for converting androgens into estrogens. By significantly reducing estrogen levels in the body, Letrozole can inhibit the growth of estrogen-sensitive tumors. This pharmaceutical compound, identified by its ATC code E07 (Gonadotropins and other ovulation stimulants), represents a cornerstone in endocrine therapy for postmenopausal women diagnosed with breast cancer.

The development of Letrozole marked a significant advancement in breast cancer treatment, offering an alternative and often superior option to older endocrine therapies like tamoxifen for certain patient populations. Approved initially by the U.S. Food and Drug Administration (FDA) in the late 1990s, it rapidly gained prominence due to its efficacy and favorable safety profile compared to some predecessors. Its introduction provided clinicians with a powerful tool to combat estrogen-driven cancers, improving progression-free survival and overall outcomes for many patients.

As a member of the third-generation aromatase inhibitors, Letrozole is highly specific to the aromatase enzyme, leading to a more targeted action and fewer off-target side effects compared to non-selective inhibitors. Its chemical structure allows for reversible binding to the heme group of the cytochrome P450 enzyme aromatase, thereby inhibiting its activity. This mechanism makes Letrozole particularly effective in postmenopausal women where the primary source of estrogen production is peripheral tissues, rather than the ovaries, which have ceased functioning.

⚙️ Mechanism of Action

Letrozole exerts its therapeutic effects by specifically inhibiting the aromatase enzyme, a member of the cytochrome P450 superfamily. Aromatase is crucial for endogenous estrogen biosynthesis, catalyzing the conversion of androgens (androstenedione and testosterone) into estrogens (estrone and estradiol, respectively). In postmenopausal women, the primary source of circulating estrogens is this peripheral conversion, occurring in adipose tissue, muscle, liver, and the breast cancer tissue itself, as the ovaries no longer produce significant amounts of estrogen.

By binding reversibly to the heme iron of the aromatase enzyme, Letrozole effectively blocks its catalytic activity. This competitive inhibition leads to a profound reduction in circulating estrogen levels, typically by over 90% in postmenopausal women. The resulting hypoestrogenic state starves estrogen-receptor-positive breast cancer cells of the growth-stimulating hormone, thereby inhibiting tumor proliferation and promoting apoptosis (programmed cell death). This targeted approach makes Letrozole highly effective in treating hormone-sensitive breast cancers.

  • Selective and potent inhibition of the aromatase enzyme.
  • Blocks the conversion of androgens to estrogens in peripheral tissues.
  • Significantly reduces circulating estrogen levels (estradiol, estrone).
  • Induces a profound hypoestrogenic state.
  • Inhibits the growth and proliferation of estrogen-receptor-positive cancer cells.

🏥️ Medical Uses & Indications

Letrozole is a versatile medication with several established medical uses, primarily in oncology, but also in reproductive medicine. Its ability to profoundly reduce estrogen levels makes it invaluable for treating conditions where estrogen acts as a growth promoter or plays a detrimental role. It is a prescription-only medication, and its use should always be guided by a healthcare professional.

Primary Indications

  • Adjuvant treatment of hormone receptor-positive early breast cancer: For postmenopausal women who have completed primary treatment (e.g., surgery, chemotherapy).
  • Extended adjuvant treatment of hormone receptor-positive early breast cancer: For postmenopausal women who have received 5 years of adjuvant tamoxifen therapy.
  • First-line treatment of hormone receptor-positive advanced breast cancer: For postmenopausal women.
  • Treatment of advanced breast cancer: For postmenopausal women with disease progression following antiestrogen therapy.
  • Neoadjuvant treatment of hormone receptor-positive breast cancer: To shrink tumors before surgery in postmenopausal women.
  • Treatment of male breast cancer: In cases of hormone-receptor-positive disease, though less common.

Secondary / Off-label Uses

  • Ovulation induction in infertility: Often used as an alternative to clomiphene citrate, especially in women with polycystic ovary syndrome (PCOS).
  • Treatment of endometriosis: To reduce estrogen-dependent lesion growth.
  • Management of gynecomastia in men: Particularly in cases where excess estrogen is implicated.
  • Precocious puberty: In some cases, to delay pubertal progression in children.

💊 Dosage & Administration

The dosage of Letrozole is highly individualized and depends on the specific medical condition being treated, the patient's age, overall health, and response to therapy. It is crucial to adhere strictly to the prescribing physician's instructions. Letrozole is typically administered orally, usually as a small tablet, and can be taken with or without food.

IndicationTypical DoseFrequencyRoute
Adjuvant Breast Cancer (Postmenopausal)2.5 mgOnce dailyOral
Advanced Breast Cancer (Postmenopausal)2.5 mgOnce dailyOral
Ovulation Induction (Off-label)2.5 mg - 5 mgOnce daily (Days 3-7 of cycle)Oral
Gynecomastia (Off-label)0.5 mg - 2.5 mgOnce daily (variable duration)Oral

Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition.

⚠️ Side Effects

Like all medications, Letrozole can cause side effects, although not everyone experiences them. Most side effects are mild to moderate and manageable. They are often related to the significant reduction in estrogen levels.

Common Side Effects (>10%)

  • Hot flashes
  • Joint pain (arthralgia)
  • Fatigue
  • Headache
  • Nausea
  • Sweating (hyperhidrosis)

Less Common (1-10%)

  • Dizziness
  • Bone pain
  • Muscle pain (myalgia)
  • Hair thinning
  • Vaginal dryness
  • Weight gain
  • Peripheral edema

Rare but Serious

  • Osteoporosis and fractures: Due to prolonged estrogen deprivation, bone mineral density can decrease, increasing fracture risk. Regular bone density monitoring is recommended.
  • Thromboembolic events: Although less common than with tamoxifen, there is a slight increased risk of blood clots, including deep vein thrombosis and pulmonary embolism.
  • Cardiac events: Some studies suggest a potential for increased cholesterol levels and, rarely, cardiac ischemia or myocardial infarction, particularly in patients with pre-existing risk factors.

🔄 Drug Interactions

Letrozole is primarily metabolized by cytochrome P450 enzymes, particularly CYP2A6 and CYP3A4. Therefore, co-administration with drugs that inhibit or induce these enzymes can alter Letrozole concentrations and potentially affect its efficacy or increase the risk of side effects. It is essential to inform your doctor about all medications, supplements, and herbal products you are taking.

  • Tamoxifen: Concomitant use with tamoxifen is not recommended as it may reduce Letrozole plasma concentrations, potentially diminishing its therapeutic effect.
  • Estrogen-containing medications: Any medications containing estrogen (e.g., hormone replacement therapy) will counteract the effects of Letrozole and should be avoided.
  • CYP3A4 inhibitors: Strong inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir) may increase Letrozole levels, potentially leading to increased side effects.
  • CYP3A4 inducers: Inducers of CYP3A4 (e.g., rifampicin, phenytoin, carbamazepine, St. John's Wort) may decrease Letrozole levels, potentially reducing its efficacy.
  • Cimetidine: While not a strong CYP inhibitor, cimetidine has been shown to slightly increase Letrozole concentrations.
  • Warfarin and other anticoagulants: Although direct interactions are not consistently reported, caution is advised, and monitoring of INR may be warranted.

🚫 Contraindications & Warnings

  • Pregnancy and breastfeeding: Letrozole is contraindicated during pregnancy due to potential harm to the fetus and during breastfeeding as it is unknown if it is excreted in human milk.
  • Premenopausal women: Not indicated for women who are premenopausal unless ovarian function has been medically or surgically suppressed.
  • Known hypersensitivity: To Letrozole or any of its excipients.
  • Severe hepatic impairment: Dose adjustment may be necessary, and caution is advised due to reduced clearance of the drug.
  • Severe renal impairment: While no specific dose adjustment is typically needed, caution is advised.
  • Concomitant estrogen therapy: Concurrent use of any estrogen-containing products will negate the effects of Letrozole.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.

❓ Frequently Asked Questions

Is Letrozole safe for long-term use?

Letrozole is often prescribed for long-term use, typically for 5 years or more, in the adjuvant treatment of early breast cancer. While generally safe, long-term use can increase the risk of certain side effects like osteoporosis. Regular monitoring of bone density, cholesterol levels, and overall health is crucial to manage these risks effectively. Your doctor will weigh the benefits against potential risks for your specific situation.

Can Letrozole be taken with food?

Yes, Letrozole can be taken with or without food. Its absorption is not significantly affected by food intake, so patients can choose to take it at a time that is most convenient for them. Consistency in timing, however, is often recommended to maintain steady drug levels in the body.

What should I do if I miss a dose of Letrozole?

If you miss a dose of Letrozole, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are unsure, consult your healthcare provider or pharmacist for advice.

Where can I buy Letrozole?

Letrozole is a prescription-only medication and cannot be purchased over-the-counter. It must be obtained through a valid prescription from a licensed healthcare provider. You can purchase Letrozole from licensed pharmacies, either physical retail pharmacies or reputable online pharmacies that require a prescription and operate within regulatory guidelines. Always ensure you are obtaining your medication from a legitimate source to guarantee its authenticity and safety.

Contact us on WhatsApp

Chat with our support team instantly on WhatsApp.

WhatsApp Chat on WhatsApp